Based on the SMILES representation CC(C)(C)[C@]1(O)CC2OC(=O)CC23C(=O)OC2OC(=O)[C@H](O)C231, the molecule has a half life time in humans after IV administration of 3.200 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
(7R,9R)-9-tert-butyl-7,9-dihydroxy-3,5,12-trioxatetracyclo[6.6.0.01,11.04,8]tetradecane-2,6,13-trione